Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-09

AUTHORS

Kwo-Chang Ueng, Sun Ningling, Abd El Maksod, Kuan-Yu Hung, Yin Yuehui

ABSTRACT

BACKGROUND: Achieving the maximum reduction in cardiovascular morbidity and mortality is the primary goal of blood pressure (BP) control. Current guidelines recommend several antihypertensive classes as first-line therapy for this purpose but the decision on which agent/s to use will likely be based upon the treating physician's clinical experience. Observational studies provide a useful way of ascertaining the efficacy and tolerability of an antihypertensive in a real-life clinical setting. OBJECTIVE: The aim of this observational study was to determine the efficacy, tolerability and physician/patient satisfaction with long-acting nifedipine (gastrointestinal therapeutic system [GITS]/osmotic-controlled release oral delivery system [OROS]) in a large multinational cohort of hypertensive patients. METHODS: This observational study was conducted in adults (aged ≥18 years) with previously untreated or treated hypertension. The decision to prescribe nifedipine 30 or 60 mg once daily was made by the treating physician. Patients then attended up to three clinic visits any time over a 12-week period when medication could be up- or down-titrated or switched. The mean reduction in systolic BP (SBP)/diastolic BP (DBP) from first visit and whether target BP (<140/<90 mmHg or <130/<80 mmHg [for patients with diabetes mellitus]) had been achieved were recorded at the final visit and stratified according to hypertension grade and presence of cardiovascular risk factors. Subjective assessment of efficacy was reported by physicians and patients. All adverse events and their possible relationship to study drug were recorded. All assessments were performed on patients who received at least one dose of nifedipine GITS/OROS. RESULTS: A total of 14 344 patients received nifedipine GITS/OROS treatment (58.7% male; 77.7% non-diabetic; mean age 57.5 years); 14 266 had at least one follow-up visit over a mean 10.2-week period, and 8000 patients had three visits over a mean 12-week period. Initially, 12 826 (89.4%) patients received nifedipine 30 mg, and 6912 patients (48.2%) overall received concomitant antihypertensive agents. The overall mean reduction in SBP/DBP was -27.7/-14.1 mmHg; BP reduction was linked to hypertension grade, age, the presence of five or more cardiovascular risk factors, and prior treatment. Target BP was achieved in 2485/7432 patients (33.4%) receiving nifedipine GITS/OROS monotherapy and in 1751/6912 (25.3%) receiving combination therapy (i.e. GITS/OROS plus any other antihypertensive agent). Non-diabetic patients with moderate (n = 3413) and high (n = 1138) risk reached their target BP goal in 62.5% and 54.2% of cases, respectively; the corresponding values in diabetic patients (moderate-added risk n = 8; high-added risk n = 684) were 75.0% and 54.8%, respectively. A total of 229 patients (1.6%) reported experiencing 286 adverse events. Physician/patient satisfaction with treatment was high. CONCLUSION: Long-acting nifedipine GITS/OROS, alone or in combination with other antihypertensive agents, provides effective and well tolerated treatment of hypertension in a broad spectrum of patients routinely seen in day-to-day clinical practice. More... »

PAGES

631-642

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/11588970-000000000-00000

DOI

http://dx.doi.org/10.2165/11588970-000000000-00000

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1031755448

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21591818


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium Channel Blockers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Delayed-Action Preparations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Delivery Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nifedipine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osmotic Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Satisfaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Internal Medicine, Chung-Shan Medical University Hospital, School of Medicine, Institute of Medicine, Chung-Shan Medical University, 110, Section 1, Jian-Guo N. Road, 402, Taichung City, Taiwan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ueng", 
        "givenName": "Kwo-Chang", 
        "id": "sg:person.0657552270.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657552270.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peking University People's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411634.5", 
          "name": [
            "Department of Cardiology, Peking University People\u2019s Hospital, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ningling", 
        "givenName": "Sun", 
        "id": "sg:person.014337040763.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014337040763.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Dr Erfan & Bagedo General Hospital, Jeddah, Saudi Arabia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maksod", 
        "givenName": "Abd El", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Taiwan University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412094.a", 
          "name": [
            "Clinical Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hung", 
        "givenName": "Kuan-Yu", 
        "id": "sg:person.01012746205.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012746205.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Second Affiliated Hospital of Chongqing Medical University", 
          "id": "https://www.grid.ac/institutes/grid.412461.4", 
          "name": [
            "Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yuehui", 
        "givenName": "Yin", 
        "id": "sg:person.014120055377.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014120055377.88"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)02527-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000631578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-199917020-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003918995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-199917020-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003918995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-199917020-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003918995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/08038020510040630", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008391304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1747-4949.2006.00041.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008682873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1747-4949.2006.00041.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008682873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1747-4949.2006.00041.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008682873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2007.03082.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009217817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.jhh.1002284", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009843127", 
          "https://doi.org/10.1038/sj.jhh.1002284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjh.0b013e3281fc975a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012616091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjh.0b013e3281fc975a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012616091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.289.19.2560", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013958161"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-199630010-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014610326", 
          "https://doi.org/10.2165/00003088-199630010-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-199630010-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014610326", 
          "https://doi.org/10.2165/00003088-199630010-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200502000-00028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014995503"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200502000-00028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014995503"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200306000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016792153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200306000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016792153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200306000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016792153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1368-5031.2005.00670.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020398230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1368-5031.2005.00670.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020398230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/vhrm.s3066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022133970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/08038020601154575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022749489"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-200666040-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028243040", 
          "https://doi.org/10.2165/00003495-200666040-00007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(04)16980-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030448727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200409000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031960910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200409000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031960910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.hyp.35.2.539", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036875441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200304000-00013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039134798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200304000-00013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039134798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjh.0b013e328010775f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043095935"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjh.0b013e328010775f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043095935"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00044011-200727080-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043891805", 
          "https://doi.org/10.2165/00044011-200727080-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/vhrm.s3661", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045041480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1291/hypres.29.789", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051454784", 
          "https://doi.org/10.1291/hypres.29.789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjr.0b013e32831fd6de", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060341545"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjr.0b013e32831fd6de", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060341545"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074597291", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082383137", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-09", 
    "datePublishedReg": "2011-09-01", 
    "description": "BACKGROUND: Achieving the maximum reduction in cardiovascular morbidity and mortality is the primary goal of blood pressure (BP) control. Current guidelines recommend several antihypertensive classes as first-line therapy for this purpose but the decision on which agent/s to use will likely be based upon the treating physician's clinical experience. Observational studies provide a useful way of ascertaining the efficacy and tolerability of an antihypertensive in a real-life clinical setting.\nOBJECTIVE: The aim of this observational study was to determine the efficacy, tolerability and physician/patient satisfaction with long-acting nifedipine (gastrointestinal therapeutic system [GITS]/osmotic-controlled release oral delivery system [OROS]) in a large multinational cohort of hypertensive patients.\nMETHODS: This observational study was conducted in adults (aged \u226518 years) with previously untreated or treated hypertension. The decision to prescribe nifedipine 30 or 60\u2009mg once daily was made by the treating physician. Patients then attended up to three clinic visits any time over a 12-week period when medication could be up- or down-titrated or switched. The mean reduction in systolic BP (SBP)/diastolic BP (DBP) from first visit and whether target BP (<140/<90\u2009mmHg or <130/<80\u2009mmHg [for patients with diabetes mellitus]) had been achieved were recorded at the final visit and stratified according to hypertension grade and presence of cardiovascular risk factors. Subjective assessment of efficacy was reported by physicians and patients. All adverse events and their possible relationship to study drug were recorded. All assessments were performed on patients who received at least one dose of nifedipine GITS/OROS.\nRESULTS: A total of 14\u2009344 patients received nifedipine GITS/OROS treatment (58.7% male; 77.7% non-diabetic; mean age 57.5 years); 14\u2009266 had at least one follow-up visit over a mean 10.2-week period, and 8000 patients had three visits over a mean 12-week period. Initially, 12\u2009826 (89.4%) patients received nifedipine 30\u2009mg, and 6912 patients (48.2%) overall received concomitant antihypertensive agents. The overall mean reduction in SBP/DBP was -27.7/-14.1\u2009mmHg; BP reduction was linked to hypertension grade, age, the presence of five or more cardiovascular risk factors, and prior treatment. Target BP was achieved in 2485/7432 patients (33.4%) receiving nifedipine GITS/OROS monotherapy and in 1751/6912 (25.3%) receiving combination therapy (i.e. GITS/OROS plus any other antihypertensive agent). Non-diabetic patients with moderate (n\u2009=\u20093413) and high (n\u2009=\u20091138) risk reached their target BP goal in 62.5% and 54.2% of cases, respectively; the corresponding values in diabetic patients (moderate-added risk n\u2009=\u20098; high-added risk n\u2009=\u2009684) were 75.0% and 54.8%, respectively. A total of 229 patients (1.6%) reported experiencing 286 adverse events. Physician/patient satisfaction with treatment was high.\nCONCLUSION: Long-acting nifedipine GITS/OROS, alone or in combination with other antihypertensive agents, provides effective and well tolerated treatment of hypertension in a broad spectrum of patients routinely seen in day-to-day clinical practice.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/11588970-000000000-00000", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100199", 
        "issn": [
          "1173-2563", 
          "1179-1918"
        ], 
        "name": "Clinical Drug Investigation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients", 
    "pagination": "631-642", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "9746b15554975b6b7f648011ba1737d82b40d021c727632abb4984139878362b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21591818"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9504817"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/11588970-000000000-00000"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1031755448"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/11588970-000000000-00000", 
      "https://app.dimensions.ai/details/publication/pub.1031755448"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000506.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165%2F11588970-000000000-00000"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/11588970-000000000-00000'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/11588970-000000000-00000'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/11588970-000000000-00000'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/11588970-000000000-00000'


 

This table displays all metadata directly associated to this object as RDF triples.

267 TRIPLES      21 PREDICATES      75 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/11588970-000000000-00000 schema:about N0bfef11ff3f24688b1a49046426fc572
2 N1dd43a56dd084b3ab75995719451acd0
3 N36fdbfa464514e04977b6da9063e7a7d
4 N50ef89f69412401f90ef71bb1171ad4d
5 N5b099075894140439fc795bbabbdbe97
6 N5de201de77db4fa18567d21be69a3adf
7 N664834cbaa184bab9cd975907c2111c1
8 N6afd6a3385ff4e29a4d9315ec4d5849d
9 N6f4f49c68bfc40d3922f80d4f18f8310
10 N788124b350d249518b17e70937a47a2a
11 N8a90c6d6dcfb434d831aee57e9754bb2
12 N8b4e1120f7ca4e01b0a9a2ed092fa149
13 N903afe2f230148b8abb40ddcb2888c42
14 N952dfc3aba644828ac121529ac50df37
15 Na34cfe89cc7f40e498550ac003607b04
16 Na8a3c4b4a9dd4592824dc52b8c33a285
17 Nbed7923ac6724f579463d9f1add8e331
18 Nbfe8a391449e40eda242fb0e6986f447
19 Nc09557b4081d4acd85438ed3f95be873
20 Ncc385547132e4713a4c364ec7e39b13b
21 anzsrc-for:11
22 anzsrc-for:1102
23 schema:author N0ac3442d471f4873be827eaea266fb20
24 schema:citation sg:pub.10.1038/sj.jhh.1002284
25 sg:pub.10.1291/hypres.29.789
26 sg:pub.10.2165/00003088-199630010-00003
27 sg:pub.10.2165/00003495-200666040-00007
28 sg:pub.10.2165/00044011-200727080-00005
29 https://app.dimensions.ai/details/publication/pub.1074597291
30 https://app.dimensions.ai/details/publication/pub.1082383137
31 https://doi.org/10.1001/jama.289.19.2560
32 https://doi.org/10.1016/s0140-6736(00)02527-7
33 https://doi.org/10.1016/s0140-6736(04)16980-8
34 https://doi.org/10.1080/08038020510040630
35 https://doi.org/10.1080/08038020601154575
36 https://doi.org/10.1097/00004872-199917020-00001
37 https://doi.org/10.1097/00004872-200304000-00013
38 https://doi.org/10.1097/00004872-200306000-00001
39 https://doi.org/10.1097/00004872-200409000-00002
40 https://doi.org/10.1097/00004872-200502000-00028
41 https://doi.org/10.1097/hjh.0b013e328010775f
42 https://doi.org/10.1097/hjh.0b013e3281fc975a
43 https://doi.org/10.1097/hjr.0b013e32831fd6de
44 https://doi.org/10.1111/j.1365-2125.2007.03082.x
45 https://doi.org/10.1111/j.1368-5031.2005.00670.x
46 https://doi.org/10.1111/j.1747-4949.2006.00041.x
47 https://doi.org/10.1161/01.hyp.35.2.539
48 https://doi.org/10.2147/vhrm.s3066
49 https://doi.org/10.2147/vhrm.s3661
50 schema:datePublished 2011-09
51 schema:datePublishedReg 2011-09-01
52 schema:description BACKGROUND: Achieving the maximum reduction in cardiovascular morbidity and mortality is the primary goal of blood pressure (BP) control. Current guidelines recommend several antihypertensive classes as first-line therapy for this purpose but the decision on which agent/s to use will likely be based upon the treating physician's clinical experience. Observational studies provide a useful way of ascertaining the efficacy and tolerability of an antihypertensive in a real-life clinical setting. OBJECTIVE: The aim of this observational study was to determine the efficacy, tolerability and physician/patient satisfaction with long-acting nifedipine (gastrointestinal therapeutic system [GITS]/osmotic-controlled release oral delivery system [OROS]) in a large multinational cohort of hypertensive patients. METHODS: This observational study was conducted in adults (aged ≥18 years) with previously untreated or treated hypertension. The decision to prescribe nifedipine 30 or 60 mg once daily was made by the treating physician. Patients then attended up to three clinic visits any time over a 12-week period when medication could be up- or down-titrated or switched. The mean reduction in systolic BP (SBP)/diastolic BP (DBP) from first visit and whether target BP (<140/<90 mmHg or <130/<80 mmHg [for patients with diabetes mellitus]) had been achieved were recorded at the final visit and stratified according to hypertension grade and presence of cardiovascular risk factors. Subjective assessment of efficacy was reported by physicians and patients. All adverse events and their possible relationship to study drug were recorded. All assessments were performed on patients who received at least one dose of nifedipine GITS/OROS. RESULTS: A total of 14 344 patients received nifedipine GITS/OROS treatment (58.7% male; 77.7% non-diabetic; mean age 57.5 years); 14 266 had at least one follow-up visit over a mean 10.2-week period, and 8000 patients had three visits over a mean 12-week period. Initially, 12 826 (89.4%) patients received nifedipine 30 mg, and 6912 patients (48.2%) overall received concomitant antihypertensive agents. The overall mean reduction in SBP/DBP was -27.7/-14.1 mmHg; BP reduction was linked to hypertension grade, age, the presence of five or more cardiovascular risk factors, and prior treatment. Target BP was achieved in 2485/7432 patients (33.4%) receiving nifedipine GITS/OROS monotherapy and in 1751/6912 (25.3%) receiving combination therapy (i.e. GITS/OROS plus any other antihypertensive agent). Non-diabetic patients with moderate (n = 3413) and high (n = 1138) risk reached their target BP goal in 62.5% and 54.2% of cases, respectively; the corresponding values in diabetic patients (moderate-added risk n = 8; high-added risk n = 684) were 75.0% and 54.8%, respectively. A total of 229 patients (1.6%) reported experiencing 286 adverse events. Physician/patient satisfaction with treatment was high. CONCLUSION: Long-acting nifedipine GITS/OROS, alone or in combination with other antihypertensive agents, provides effective and well tolerated treatment of hypertension in a broad spectrum of patients routinely seen in day-to-day clinical practice.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree false
56 schema:isPartOf N5451a16180c04b5299f8aa59102875f6
57 N6e34d9fcbaa54934b27b22f5a7d49c47
58 sg:journal.1100199
59 schema:name Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients
60 schema:pagination 631-642
61 schema:productId N335de29eb73344929dedd03cb9e1e62d
62 Na628c47bd6104281b4ec5c50c2017f7e
63 Nbf3d60173b63414198e81e09479c7fab
64 Nf1cf16d51d504e3b873f4e0e5cf9c322
65 Nf1face5432c14d73814ca1c394d14645
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031755448
67 https://doi.org/10.2165/11588970-000000000-00000
68 schema:sdDatePublished 2019-04-10T15:50
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N7eef51e397764bd39e0036982bece40c
71 schema:url http://link.springer.com/10.2165%2F11588970-000000000-00000
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N0ac3442d471f4873be827eaea266fb20 rdf:first sg:person.0657552270.84
76 rdf:rest Nd53b2ad1c87942759c3bcbdbf62220e4
77 N0bfef11ff3f24688b1a49046426fc572 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Female
79 rdf:type schema:DefinedTerm
80 N1dd43a56dd084b3ab75995719451acd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Male
82 rdf:type schema:DefinedTerm
83 N335de29eb73344929dedd03cb9e1e62d schema:name doi
84 schema:value 10.2165/11588970-000000000-00000
85 rdf:type schema:PropertyValue
86 N36fdbfa464514e04977b6da9063e7a7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Risk Factors
88 rdf:type schema:DefinedTerm
89 N45f7f399a84144fa8aedf056f5dd6ceb schema:name Department of Internal Medicine, Chung-Shan Medical University Hospital, School of Medicine, Institute of Medicine, Chung-Shan Medical University, 110, Section 1, Jian-Guo N. Road, 402, Taichung City, Taiwan
90 rdf:type schema:Organization
91 N50ef89f69412401f90ef71bb1171ad4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Prospective Studies
93 rdf:type schema:DefinedTerm
94 N5451a16180c04b5299f8aa59102875f6 schema:volumeNumber 31
95 rdf:type schema:PublicationVolume
96 N5b099075894140439fc795bbabbdbe97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Patient Satisfaction
98 rdf:type schema:DefinedTerm
99 N5de201de77db4fa18567d21be69a3adf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Adult
101 rdf:type schema:DefinedTerm
102 N617430fffaac4eeba446436e883ff4ac schema:affiliation Ne7c6ebedf88246c1b7a91847a6bec5a3
103 schema:familyName Maksod
104 schema:givenName Abd El
105 rdf:type schema:Person
106 N664834cbaa184bab9cd975907c2111c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Drug Therapy, Combination
108 rdf:type schema:DefinedTerm
109 N6afd6a3385ff4e29a4d9315ec4d5849d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Middle Aged
111 rdf:type schema:DefinedTerm
112 N6e34d9fcbaa54934b27b22f5a7d49c47 schema:issueNumber 9
113 rdf:type schema:PublicationIssue
114 N6f4f49c68bfc40d3922f80d4f18f8310 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Nifedipine
116 rdf:type schema:DefinedTerm
117 N788124b350d249518b17e70937a47a2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N7eef51e397764bd39e0036982bece40c schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 N8a90c6d6dcfb434d831aee57e9754bb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Calcium Channel Blockers
124 rdf:type schema:DefinedTerm
125 N8b4e1120f7ca4e01b0a9a2ed092fa149 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Delayed-Action Preparations
127 rdf:type schema:DefinedTerm
128 N903afe2f230148b8abb40ddcb2888c42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Osmotic Pressure
130 rdf:type schema:DefinedTerm
131 N952dfc3aba644828ac121529ac50df37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Follow-Up Studies
133 rdf:type schema:DefinedTerm
134 Na34cfe89cc7f40e498550ac003607b04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Hypertension
136 rdf:type schema:DefinedTerm
137 Na628c47bd6104281b4ec5c50c2017f7e schema:name readcube_id
138 schema:value 9746b15554975b6b7f648011ba1737d82b40d021c727632abb4984139878362b
139 rdf:type schema:PropertyValue
140 Na8a3c4b4a9dd4592824dc52b8c33a285 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Antihypertensive Agents
142 rdf:type schema:DefinedTerm
143 Nbed7923ac6724f579463d9f1add8e331 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Aged
145 rdf:type schema:DefinedTerm
146 Nbf3d60173b63414198e81e09479c7fab schema:name nlm_unique_id
147 schema:value 9504817
148 rdf:type schema:PropertyValue
149 Nbfe8a391449e40eda242fb0e6986f447 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Drug Delivery Systems
151 rdf:type schema:DefinedTerm
152 Nc09557b4081d4acd85438ed3f95be873 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Dose-Response Relationship, Drug
154 rdf:type schema:DefinedTerm
155 Nc14d4176782c45f2bbaf48f63b44f5d4 rdf:first sg:person.01012746205.27
156 rdf:rest Nf45ce0470e2d4c57aa9fd79de1cd04c6
157 Ncc385547132e4713a4c364ec7e39b13b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Blood Pressure
159 rdf:type schema:DefinedTerm
160 Nd53b2ad1c87942759c3bcbdbf62220e4 rdf:first sg:person.014337040763.92
161 rdf:rest Ne5e1a389a5ba4875ac8d78d800de0701
162 Ne5e1a389a5ba4875ac8d78d800de0701 rdf:first N617430fffaac4eeba446436e883ff4ac
163 rdf:rest Nc14d4176782c45f2bbaf48f63b44f5d4
164 Ne7c6ebedf88246c1b7a91847a6bec5a3 schema:name Dr Erfan & Bagedo General Hospital, Jeddah, Saudi Arabia
165 rdf:type schema:Organization
166 Nf1cf16d51d504e3b873f4e0e5cf9c322 schema:name dimensions_id
167 schema:value pub.1031755448
168 rdf:type schema:PropertyValue
169 Nf1face5432c14d73814ca1c394d14645 schema:name pubmed_id
170 schema:value 21591818
171 rdf:type schema:PropertyValue
172 Nf45ce0470e2d4c57aa9fd79de1cd04c6 rdf:first sg:person.014120055377.88
173 rdf:rest rdf:nil
174 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
175 schema:name Medical and Health Sciences
176 rdf:type schema:DefinedTerm
177 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
178 schema:name Cardiorespiratory Medicine and Haematology
179 rdf:type schema:DefinedTerm
180 sg:journal.1100199 schema:issn 1173-2563
181 1179-1918
182 schema:name Clinical Drug Investigation
183 rdf:type schema:Periodical
184 sg:person.01012746205.27 schema:affiliation https://www.grid.ac/institutes/grid.412094.a
185 schema:familyName Hung
186 schema:givenName Kuan-Yu
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012746205.27
188 rdf:type schema:Person
189 sg:person.014120055377.88 schema:affiliation https://www.grid.ac/institutes/grid.412461.4
190 schema:familyName Yuehui
191 schema:givenName Yin
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014120055377.88
193 rdf:type schema:Person
194 sg:person.014337040763.92 schema:affiliation https://www.grid.ac/institutes/grid.411634.5
195 schema:familyName Ningling
196 schema:givenName Sun
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014337040763.92
198 rdf:type schema:Person
199 sg:person.0657552270.84 schema:affiliation N45f7f399a84144fa8aedf056f5dd6ceb
200 schema:familyName Ueng
201 schema:givenName Kwo-Chang
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657552270.84
203 rdf:type schema:Person
204 sg:pub.10.1038/sj.jhh.1002284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009843127
205 https://doi.org/10.1038/sj.jhh.1002284
206 rdf:type schema:CreativeWork
207 sg:pub.10.1291/hypres.29.789 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051454784
208 https://doi.org/10.1291/hypres.29.789
209 rdf:type schema:CreativeWork
210 sg:pub.10.2165/00003088-199630010-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014610326
211 https://doi.org/10.2165/00003088-199630010-00003
212 rdf:type schema:CreativeWork
213 sg:pub.10.2165/00003495-200666040-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028243040
214 https://doi.org/10.2165/00003495-200666040-00007
215 rdf:type schema:CreativeWork
216 sg:pub.10.2165/00044011-200727080-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043891805
217 https://doi.org/10.2165/00044011-200727080-00005
218 rdf:type schema:CreativeWork
219 https://app.dimensions.ai/details/publication/pub.1074597291 schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1082383137 schema:CreativeWork
221 https://doi.org/10.1001/jama.289.19.2560 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013958161
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/s0140-6736(00)02527-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000631578
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/s0140-6736(04)16980-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030448727
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1080/08038020510040630 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008391304
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1080/08038020601154575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022749489
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1097/00004872-199917020-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003918995
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1097/00004872-200304000-00013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039134798
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1097/00004872-200306000-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016792153
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1097/00004872-200409000-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031960910
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1097/00004872-200502000-00028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014995503
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1097/hjh.0b013e328010775f schema:sameAs https://app.dimensions.ai/details/publication/pub.1043095935
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1097/hjh.0b013e3281fc975a schema:sameAs https://app.dimensions.ai/details/publication/pub.1012616091
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1097/hjr.0b013e32831fd6de schema:sameAs https://app.dimensions.ai/details/publication/pub.1060341545
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1111/j.1365-2125.2007.03082.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009217817
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1111/j.1368-5031.2005.00670.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1020398230
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1111/j.1747-4949.2006.00041.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1008682873
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1161/01.hyp.35.2.539 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036875441
254 rdf:type schema:CreativeWork
255 https://doi.org/10.2147/vhrm.s3066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022133970
256 rdf:type schema:CreativeWork
257 https://doi.org/10.2147/vhrm.s3661 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045041480
258 rdf:type schema:CreativeWork
259 https://www.grid.ac/institutes/grid.411634.5 schema:alternateName Peking University People's Hospital
260 schema:name Department of Cardiology, Peking University People’s Hospital, Beijing, China
261 rdf:type schema:Organization
262 https://www.grid.ac/institutes/grid.412094.a schema:alternateName National Taiwan University Hospital
263 schema:name Clinical Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan
264 rdf:type schema:Organization
265 https://www.grid.ac/institutes/grid.412461.4 schema:alternateName Second Affiliated Hospital of Chongqing Medical University
266 schema:name Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
267 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...